Mechanisms and Treatment of Raynaud’s Disease and Phenomenon
Author:
Freedman Robert R.
Reference41 articles.
1. Belch, J. J. E, Newman, P., Drury, J. K., McKenzie, E, Capell, H., Leiberman, P., Forbes, C. D., & Prentice, C. R. M. (1983). Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud’s syndrome. The Lancet, 313–315. 2. Coffman, J. D. (1991). Raynaud’s phenomenon. Hypertension, 17, 593–602. 3. Coffman, J. D., & Cohen, A. S. (1971). Total and capillary fingertip blood flow in Raynaud’s phenomenon. New England Journal of Medicine, 285, 259–263. 4. Coffman, J. D., Clement, D. L., Creager, M. A., Dormandy, J. A., Janssens, M. M.-L., McKendry, R. J. R., Murray, G. D., & Nielsen, S. L. (1989). International study of ketanserin in Raynaud’s phenomenon. American Journal of Medicine, 87, 264–268. 5. Cohen, R., & Coffman, J. (1981). Beta-adrenergic vasodilator mechanism in the finger. Circulation Research, 49, 1196–1201.
|
|